Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmasonics

Full company profile

uuid000wv3b

Namestring
Pharmasonics
Company typeenum
Private
Founded yearint
1995
Short descriptiontext

Pharmasonics is a Sunnyvale, California-based medical device company that developed therapeutic ultrasound catheter-based technology. Founded in 1995, the company is privately held with 11–50 employees and last raised capital in 1998.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSunnyvale, United States
HQ citystring
Sunnyvale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
therapeutic ultrasound, catheter-based devices, interventional cardiology, medical device development, ultrasound ablation
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Therapeutic Ultrasound Catheters
No data
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pharmasonics develops therapeutic ultrasound catheter-based technology for medical applications. The company focuses on catheter-delivered ultrasound energy as a therapeutic modality, with Sunnyvale, California as its base of operations. No specific named products, indications, or commercialization stage can be confirmed because the company website is currently parked and no active product information is accessible.

Differentiator
Functional benefit
Problem solved
No data
Peers7 records
TypeDirect peer
Description

Penumbra manufactures catheter-based mechanical thrombectomy and aspiration systems for vascular and neurovascular indications, directly competing in the same procedural niches (clot removal, vascular intervention) that Pharmasonics' ultrasound catheter was designed to address.

TypeBroad incumbent
Description

AngioDynamics manufactures a broad portfolio of interventional medical devices, including catheter-based therapies (e.g., NanoKnife, AngioVac) for vascular and oncology indications that overlap with Pharmasonics' therapeutic catheter area but span a wider portfolio.

TypeDirect peer
Description

Inari Medical develops catheter-based therapeutic devices (FlowTriever, ClotTriever) for venous thromboembolism and other vascular conditions, addressing the same therapeutic indications Pharmasonics' ultrasound catheter was designed to treat.

TypeOthers
Description

Surmodics provides hydrophilic and drug-coated catheter surface technologies used in delivery systems, relevant to Pharmasonics as an enabling technology provider in the catheter-based therapeutic device supply chain rather than a direct competitor.

TypeDirect peer
Description

Historical direct peer that developed ultrasonic catheter technology for vascular thrombectomy applications in the same era as Pharmasonics. Both companies pursued the late-1990s concept of catheter-delivered ultrasonic energy to disrupt or treat thrombus.

6EKOS Corporation (now part of Boston Scientific)
TypeDirect peer
Description

EKOS developed catheter-based therapeutic ultrasound systems (EKOS EkoSonic) for ultrasound-assisted thrombolysis, the most directly comparable product and category to Pharmasonics' therapeutic ultrasound catheter technology. EKOS was acquired by BTG and subsequently integrated into Boston Scientific.

TypeBroad incumbent
Description

Teleflex, through its acquisition of Vascular Solutions, develops and commercializes interventional vascular products including specialty catheters and therapeutic devices that overlap with the catheter-based therapeutic space where Pharmasonics operated.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmasonics

Therapeutic Ultrasound Catheterspharmasonics.com

Pharmasonics is a Sunnyvale, California-based medical device company that developed therapeutic ultrasound catheter-based technology. Founded in 1995, the company is privately held with 11–50 employees and last raised capital in 1998.

Pharmasonics firmographics

Firmographics
Name
Pharmasonics
Website
https://pharmasonics.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Pharmasonics is a Sunnyvale, California-based medical device company that developed therapeutic ultrasound catheter-based technology. Founded in 1995, the company is privately held with 11–50 employees and last raised capital in 1998.
Ownership category
akta.pro rank

Where Pharmasonics is headquartered

Location

Headquarters

HQ city
Sunnyvale
HQ country
United States
HQ region
North America

Markets served

Pharmasonics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Pharmasonics product offering

Product offering

Core offering

Pharmasonics develops therapeutic ultrasound catheter-based technology for medical applications. The company focuses on catheter-delivered ultrasound energy as a therapeutic modality, with Sunnyvale, California as its base of operations. No specific named products, indications, or commercialization stage can be confirmed because the company website is currently parked and no active product information is accessible.

Differentiator

Problem solved

Functional benefit

Companies that use Pharmasonics

Customer profile

Ideal customer profiles1 record

Pharmasonics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharmasonics competitors and assessment

Company assessment

Direct peers

  • Penumbra: Penumbra manufactures catheter-based mechanical thrombectomy and aspiration systems for vascular and neurovascular indications, directly competing in the same procedural niches (clot removal, vascular intervention) that Pharmasonics' ultrasound catheter was designed to address.
  • Inari Medical: Inari Medical develops catheter-based therapeutic devices (FlowTriever, ClotTriever) for venous thromboembolism and other vascular conditions, addressing the same therapeutic indications Pharmasonics' ultrasound catheter was designed to treat.
  • Omnisonics Medical Technologies: Historical direct peer that developed ultrasonic catheter technology for vascular thrombectomy applications in the same era as Pharmasonics. Both companies pursued the late-1990s concept of catheter-delivered ultrasonic energy to disrupt or treat thrombus.
  • EKOS Corporation (now part of Boston Scientific): EKOS developed catheter-based therapeutic ultrasound systems (EKOS EkoSonic) for ultrasound-assisted thrombolysis, the most directly comparable product and category to Pharmasonics' therapeutic ultrasound catheter technology. EKOS was acquired by BTG and subsequently integrated into Boston Scientific.

Broad incumbents

  • AngioDynamics: AngioDynamics manufactures a broad portfolio of interventional medical devices, including catheter-based therapies (e.g., NanoKnife, AngioVac) for vascular and oncology indications that overlap with Pharmasonics' therapeutic catheter area but span a wider portfolio.
  • Teleflex (Vascular Solutions): Teleflex, through its acquisition of Vascular Solutions, develops and commercializes interventional vascular products including specialty catheters and therapeutic devices that overlap with the catheter-based therapeutic space where Pharmasonics operated.

Others

  • Surmodics: Surmodics provides hydrophilic and drug-coated catheter surface technologies used in delivery systems, relevant to Pharmasonics as an enabling technology provider in the catheter-based therapeutic device supply chain rather than a direct competitor.

Market position

Customer concentration

Pharmasonics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmasonics leadership team

Management profile

Number of profiles

Pharmasonics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmasonics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmasonics

What does Pharmasonics do?

Pharmasonics develops therapeutic ultrasound catheter-based technology for medical applications. The company focuses on catheter-delivered ultrasound energy as a therapeutic modality, with Sunnyvale, California as its base of operations. No specific named products, indications, or commercialization stage can be confirmed because the company website is currently parked and no active product information is accessible.

When was Pharmasonics founded?

Pharmasonics was founded in 1995. It employs 11 to 50 people.

Where is Pharmasonics based?

Pharmasonics is headquartered in Sunnyvale, United States, in the North America region.

Who are Pharmasonics's main competitors?

Direct peers on record are Penumbra, Inari Medical, Omnisonics Medical Technologies and EKOS Corporation (now part of Boston Scientific). Broad incumbents are AngioDynamics and Teleflex (Vascular Solutions). Surmodics is listed as an others.

Does Pharmasonics have an API?

No public API is recorded for Pharmasonics.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales